Direct-to-Consumer Genomics in the CrosshairsDirect-to-Consumer Genomics in the Crosshairs

Personal genomics seemed to be on a rocketship trajectory until the FDA sent a warning letter to 23andMe questioning marketing materials that bordered on self diagnosis.